Skip navigation

Chemical Organic Chemicals

Filtered by interactions with: EGF | Show all interactions
1–50 of 428 results.
  Interacting Chemical Interacting Gene Interaction References Organisms
1. 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester EGF 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [EGF protein affects the localization of PRKCB protein] 1 1
2. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone EGF AG 1879 inhibits the reaction [[EGF protein co-treated with 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone] results in decreased activity of ABCC2 protein] 1 1
3. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone EGF Dideoxyadenosine inhibits the reaction [[EGF protein co-treated with 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone] results in decreased activity of ABCC2 protein] 1 1
4. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone EGF [EGF protein co-treated with 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone] results in decreased activity of ABCC2 protein 1 1
5. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone EGF Protein Kinase Inhibitors inhibits the reaction [[EGF protein co-treated with 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone] results in decreased activity of ABCC2 protein] 1 1
6. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea EGF 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea results in increased expression of EGF mRNA 1 1
7. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine EGF 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] 3 1
8. 2,2',3',4,4',5-hexachlorobiphenyl EGF 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of EGF mRNA 1 1
9. 2,2',3',4,4',5-hexachlorobiphenyl EGF [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA 1 1
10. 2,2',4,4'-tetrabromodiphenyl ether EGF 2,2',4,4'-tetrabromodiphenyl ether metabolite inhibits the reaction [[EGF protein co-treated with FGF2 protein] results in increased phosphorylation of and results in increased activity of MAPK7 protein] 1 1
11. 2',3,3',4',5-pentachloro-4-hydroxybiphenyl EGF 2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of EGF mRNA 1 1
12. 2,4,4'-trichlorobiphenyl EGF [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA 1 1
13. 2,4,5,2',4',5'-hexachlorobiphenyl EGF [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA 1 1
14. 2,4,5,2',5'-pentachlorobiphenyl EGF [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA 1 1
15. 2,4-dinitrotoluene EGF 2,4-dinitrotoluene affects the expression of EGF mRNA 1 1
16. 2,5,2',5'-tetrachlorobiphenyl EGF [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA 1 1
17. 2,6-dinitrotoluene EGF 2,6-dinitrotoluene affects the expression of EGF mRNA 1 1
18. 3,4,5,3',4'-pentachlorobiphenyl EGF 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EGF mRNA 1 1
19. 3,5,3',4',5'-pentahydroxy-stilbene EGF 3,5,3',4',5'-pentahydroxy-stilbene inhibits the reaction [EGF protein results in increased activity of PIK3R1 protein] 1  
20. 3,5,3',4',5'-pentahydroxy-stilbene EGF 3,5,3',4',5'-pentahydroxy-stilbene results in decreased susceptibility to EGF protein 1  
21. 4,4'-diaminodiphenylmethane EGF 4,4'-diaminodiphenylmethane results in decreased expression of EGF mRNA 2 2
22. 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide EGF 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Cisplatin]] 1 1
23. 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide EGF 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to gemcitabine]] 1 1
24. 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide EGF [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased activity of [SMAD2 protein co-treated with SMAD3 protein]] inhibits the reaction [EGF protein results in increased chemical synthesis of Hyaluronic Acid] 1  
25. 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide EGF [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased activity of [SMAD2 protein co-treated with SMAD3 protein]] which results in decreased susceptibility to EGF protein 1  
26. 4,5-dianilinophthalimide EGF 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone] 1 1
27. 4-tert-octylphenol EGF 4-tert-octylphenol results in increased expression of EGF mRNA 1 1
28. 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime EGF 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] 1 1
29. 6-chrysenamine EGF 6-chrysenamine inhibits the reaction [EGF protein binds to EGFR protein] 1 1
30. Acetaldehyde EGF chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] 1 1
31. Acetaldehyde EGF chelerythrine inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] 1 1
32. Acetaldehyde EGF EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein] 1 1
33. Acetaldehyde EGF EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein] 1 1
34. Acetaldehyde EGF EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin] 1 1
35. Acetaldehyde EGF EGF protein results in decreased susceptibility to Acetaldehyde 1 1
36. Acetaldehyde EGF PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]] 1 1
37. Acetaldehyde EGF PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] 1 1
38. Acetaldehyde EGF PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] 1 1
39. Acetaldehyde EGF PRKCB protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] 1 1
40. Acetaldehyde EGF PRKCE protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] 1 1
41. Acetaldehyde EGF PRKCE protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] 1 1
42. Acetaldehyde EGF Ro 32-0432 inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] 1 1
43. Acetaldehyde EGF Ro 32-0432 inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] 1 1
44. Acetaminophen EGF [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA] 1 1
45. Acetylcysteine EGF Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] 1 1
46. Acetylcysteine EGF Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides] 1 1
47. afimoxifene EGF 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[afimoxifene co-treated with EGF protein] results in increased expression of CDH1 protein] 1 1
48. afimoxifene EGF [afimoxifene co-treated with EGF protein] results in increased expression of CDH1 mRNA 1 1
49. afimoxifene EGF [afimoxifene co-treated with EGF protein] results in increased expression of CDH1 protein 1 1
50. afimoxifene EGF AG 1879 inhibits the reaction [[afimoxifene co-treated with EGF protein] results in increased expression of CDH1 protein] 1 1
1–50 of 428 results.